Review
doi: 10.1136/bmj.320.7232.424.
Regular review: tumour markers in malignancies
Affiliations
- PMID: 10669448
- PMCID: PMC1117546
- DOI: 10.1136/bmj.320.7232.424
Item in Clipboard
Review
Regular review: tumour markers in malignancies
BMJ.
.
Erratum in
- BMJ 2000 Mar 25;320(7238):867
No abstract available
Figures
Philadelphia chromosome in chronic myeloid leukaemia (fluorescent in situ hybridisation)
Comment in
-
Tumour markers in malignancies. Two isoforms of oestrogen receptor are now known to exist.BMJ. 2000 Aug 5;321(7257):379-80. BMJ. 2000. PMID: 10991559 Free PMC article. No abstract available.
-
Tumour markers in malignancies. CA19.9 is useful in several cancers.BMJ. 2000 Aug 5;321(7257):380. BMJ. 2000. PMID: 10991560 No abstract available.
-
Tumour markers in malignancies. Monocolonal immunoglobulin and beta human chorionic gonadotrophin.BMJ. 2000 Aug 5;321(7257):380. BMJ. 2000. PMID: 10991561 No abstract available.
Similar articles
-
The diagnostic value of beta-catenin immunohistochemistry.Adv Anat Pathol. 2005 Nov;12(6):350-6. doi: 10.1097/01.pap.0000194628.58501.71. Adv Anat Pathol. 2005. PMID: 16330931 Review.
-
Comparing breast biomarker status between routine immunohistochemistry and FISH studies and Oncotype DX testing, a study of 610 cases.Breast J. 2018 Nov;24(6):889-893. doi: 10.1111/tbj.13110. Epub 2018 Sep 19. Breast J. 2018. PMID: 30230095
-
AMACR: an emerging diagnostic and prognostic tool in systemic malignancies.Int Urol Nephrol. 2013 Apr;45(2):439-40. doi: 10.1007/s11255-013-0393-3. Epub 2013 Feb 8. Int Urol Nephrol. 2013. PMID: 23392962 No abstract available.
-
Pathology and the Internet.Adv Anat Pathol. 2003 Jul;10(4):234-5. doi: 10.1097/00125480-200307000-00007. Adv Anat Pathol. 2003. PMID: 12826830 Review. No abstract available.
-
Equivalency of RT-PCR and immunohistochemistry: fact or factoid.Breast Cancer Res Treat. 2009 Jul;116(1):145-7. doi: 10.1007/s10549-008-0176-1. Epub 2008 Sep 12. Breast Cancer Res Treat. 2009. PMID: 18787946 Review. No abstract available.
Cited by
-
The gene expression profiles of canine mammary cancer cells grown with carcinoma-associated fibroblasts (CAFs) as a co-culture in vitro.BMC Vet Res. 2012 Mar 27;8:35. doi: 10.1186/1746-6148-8-35. BMC Vet Res. 2012. PMID: 22453032 Free PMC article.
-
Genetics 101: polymerase chain reaction.CMAJ. 2002 Oct 29;167(9):1032-3. CMAJ. 2002. PMID: 12403744 Free PMC article. No abstract available.
-
The activity of alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) in the sera of patients with brain cancer.Neurochem Res. 2014 Dec;39(12):2313-8. doi: 10.1007/s11064-014-1402-3. Epub 2014 Oct 10. Neurochem Res. 2014. PMID: 25300996 Free PMC article.
-
FGF2-Derived PeptibodyF2-MMAE Conjugate for Targeted Delivery of Cytotoxic Drugs into Cancer Cells Overexpressing FGFR1.Cancers (Basel). 2020 Oct 15;12(10):2992. doi: 10.3390/cancers12102992. Cancers (Basel). 2020. PMID: 33076489 Free PMC article.
-
Tumor markers in clinical practice: General principles and guidelines.Indian J Med Paediatr Oncol. 2009 Jan;30(1):1-8. doi: 10.4103/0971-5851.56328. Indian J Med Paediatr Oncol. 2009. PMID: 20668599 Free PMC article.
References
-
- Melo JV. The molecular biology of chronic myeloid leukemia. Leukemia. 1996;10:751–756. - PubMed
-
- Heim S, Mitelmann F. Cancer cytogenetics. Chromosomal and molecular genetic aberrations of tumor cells. 2nd ed. New York: Wiley; 1994.
-
- Hunerbein M. The value of tumor markers in colorectal cancer. Recent Results Cancer Res. 1998;146:48–55. - PubMed
-
- Lamerz R. AFP isoforms and their clinical significance. Anticancer Res. 1997;17:2927–2930. - PubMed
-
- Kuban DA, El-Mahdi A, Schellhammer PF. PSA for outcome prediction and posttreatment evaluation following radiation for prostate cancer: do we know how to use it? Semin Oncol. 1998;8:72–80. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
